Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer

Ads

You May Also Like

AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders

ALBANY, N.Y., April 06, 2017 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the “Company”), a ...

BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget

Minneapolis, MN, June 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

Principia Biopharma Appoints Dolca Thomas, M.D. as Chief Medical Officer

- Succession designed to lead Principia through next phase of growth as a clinical-stage company ...